Ledger.Open graph →
SEC Form D · Amendment · filed February 21, 2014

Elcelyx Therapeutics, Inc

Offering
$24.7M
Sold
$24.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Brook E. Byers · SAN DIEGO, CADirectorGinger R. Graham · SAN DIEGO, CADirectorRalph E. Christofferson · SAN DIEGO, CADirectorMark R. Wiggins · SAN DIEGO, CAExecMartin R. Brown · SAN DIEGO, CAExecRichard J. Barry · SAN DIEGO, CADirectorJim R. Glasheen · SAN DIEGO, CADirectorMark R. Fineman · SAN DIEGO, CAExecAlain D. Baron · SAN DIEGO, CAExec · DirectorGene T. Menn · Montgomery, TXDirectorDavid E. Schulz · New Ulm, TXDirectorMichael E. Aldredge · Bellville, TXDirectorRonald T. Rudloff · Cypress, TXExecRichard E. Schilling · Fayetteville, TXExecThomas L. Gustafson · Okoboji, IADirectorJames E. Freund · Hudson, WIDirectorJohn C. Walker · San Francisco, CAExecRichard N. Massey · Jacksonville, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗